[Influenza vaccination in HIV infected children: immunologic and viral load changes]
- PMID: 12973507
- DOI: 10.2223/jped.934
[Influenza vaccination in HIV infected children: immunologic and viral load changes]
Abstract
Objective: To identify whether influenza immunization in HIV infected children could increase HIV viral load and decrease CD4+ lymphocytes count as a consequence of the response induced by a T cell-dependent antigen.
Methods: Prospective, descriptive study, with 51 HIV infected children, vaccinated against influenza in 1999, in Florianópolis, Brazil. Blood samples were collected at three different moments: on the immunization day; between 14 and 20 days later; between 60 and 90 days later. Plasma levels of HIV viral load and CD4+ lymphocytes count were determined. Friedman ANOVA test, Student t test for dependent samples, Bonferroni correction and Wilcoxon matched test were performed for statistical analysis.
Results: Children's mean age was 6.08 years (1 to 12.9 years). The medians of CD4+ lymphocyte count on vaccination day and at the other two moments were 789, 645 and 768 cells/mm(3), respectively. A significant reduction was observed in the CD4+ lymphocyte count between the first and the second analyses, but the same did not happen between the first and the third analyses. There was no significant difference of CD4+ lymphocyte percentage between the first and the second analyses. The median of HIV viral load values in log10 copies/ml was 4.38, 4.30 and 4.25, at the three moments respectively. Eight out of 44 patients (18.2%) showed increase > or =0.5 log 10 copies/ml in HIV viral load between the first and the second analysis and among these, four returned to levels close to their base levels in the third analysis.
Conclusions: There was no significant change in the CD4+ lymphocyte percentage, in spite of a transitory increase in HIV viral load after influenza vaccination. Caution should be used when administering vaccine against flu to children with no stable clinical and immunological conditions, mainly if they are not under effective anti-retroviral therapeutics.
Comment in
-
[Influenza immunization risks in HIV infected children].J Pediatr (Rio J). 2003 Jan-Feb;79(1):5-6. J Pediatr (Rio J). 2003. PMID: 12973503 Portuguese. No abstract available.
Similar articles
-
Comparison of the effects of acute influenza infection and Influenza vaccination on HIV viral load and CD4 cell counts.J Clin Virol. 2003 Apr;26(3):307-15. doi: 10.1016/s1386-6532(02)00047-1. J Clin Virol. 2003. PMID: 12637080 Review.
-
Immunization with both T cell-dependent and T cell-independent vaccines augments HIV viral load secondarily to stimulation of tumor necrosis factor alpha.AIDS Res Hum Retroviruses. 1998 Jun 10;14(9):727-34. doi: 10.1089/aid.1998.14.727. AIDS Res Hum Retroviruses. 1998. PMID: 9643372
-
Restored humoral immune response to influenza vaccination in HIV-infected adults treated with highly active antiretroviral therapy.AIDS. 1998 Dec 3;12(17):F217-23. doi: 10.1097/00002030-199817000-00002. AIDS. 1998. PMID: 9863863
-
Abnormal humoral immune response to influenza vaccination in pediatric type-1 human immunodeficiency virus infected patients receiving highly active antiretroviral therapy.Mem Inst Oswaldo Cruz. 2007 Jun;102(4):501-8. doi: 10.1590/s0074-02762007005000055. Mem Inst Oswaldo Cruz. 2007. PMID: 17612772
-
[Deep lung--cellular reaction to HIV].Rev Port Pneumol. 2007 Mar-Apr;13(2):175-212. Rev Port Pneumol. 2007. PMID: 17492233 Review. Portuguese.
Cited by
-
Long-term immunogenicity after one and two doses of a monovalent MF59-adjuvanted A/H1N1 Influenza virus vaccine coadministered with the seasonal 2009-2010 nonadjuvanted Influenza virus vaccine in HIV-infected children, adolescents, and young adults in a randomized controlled trial.Clin Vaccine Immunol. 2011 Sep;18(9):1503-9. doi: 10.1128/CVI.05200-11. Epub 2011 Jul 27. Clin Vaccine Immunol. 2011. PMID: 21795458 Free PMC article. Clinical Trial.
-
Safety and immunogenicity of two influenza virus subunit vaccines, with or without MF59 adjuvant, administered to human immunodeficiency virus type 1-seropositive and -seronegative adults.Clin Vaccine Immunol. 2008 Feb;15(2):253-9. doi: 10.1128/CVI.00316-07. Epub 2007 Nov 14. Clin Vaccine Immunol. 2008. PMID: 18003811 Free PMC article. Clinical Trial.
-
HIV virological suppression influences response to the AS03-adjuvanted monovalent pandemic influenza A H1N1 vaccine in HIV-infected children.Influenza Other Respir Viruses. 2014 May;8(3):360-6. doi: 10.1111/irv.12243. Epub 2014 Feb 18. Influenza Other Respir Viruses. 2014. PMID: 24548473 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials